教育、工作经历

03/2017-至今，博士后，暨南大学生物医学工程

09/2013-06/2016，博士，暨南大学细胞生物学

09/2009-06/2012，硕士，广西师范大学

09/2005-06/2009，学士，广西师范大学

科研项目

1、中国博士后科学基金面上二等：靶向性有机硒对肝癌放疗的增敏活性及其机制研究、资助编号：2018M633274, 起止时间：2019.01-2020.03，5万元、项目主持人；

发表论文

(1) Delong Zeng(#); Jianfu Zhao(#); Kar-Him Luk; Siu-To Cheung; Ka Hing Wong(*); Tianfeng Chen(#), Potentiation of In Vivo Anticancer Efficacy of Selenium Nanoparticles by Mushroom Polysaccharides Surface Decoration, Journal of Agricultural and Food Chemistry. 2019 (Accepted, DOI: 10.1021/acs.jafc.9b00193)

(2) Delong Zeng(#); Shulin Deng(#); Chengcheng Sang; Jianfu Zhao(*); Tianfeng Chen(*), Rational Design of Cancer-Targeted Selenadiazole Derivative as Efficient Radiosensitizer for Precise Cancer Therapy, Bioconjugate chemistry, 2018.5.17, 29(6): 2039~2049

(3) Shulin Deng(#); Delong Zeng(#); Yi Luo; Jianfu Zhao; Xiaoling Li; Zhennan Zhao; Tianfeng Chen(*), Enhancement of cell uptake and antitumor activity of selenadiazole derivatives through interaction and delivery by serum albumin, RSC ADVANCES, 2017, 7(27): 16721~16729   

(4) Jianfu Zhao(#); Delong Zeng; Yuedan Liu; Yi Luo; Shengbin Ji; Xiaoling Li(*); Tianfeng Chen(*), Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways, METALLOMICS, 2017.5, 9(5): 535~545

(5) Delong Zeng(#); Maoxing Liu; Jingxuan Pan(*), Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells, Oncotarget, 2016.12.02, 8(2): 3396~3411

专利申请  

(1) 陈填烽; 曾德龙; 邓树林, 苯并硒二唑的衍生物及其应用, 2017.10.24, 中国, 201711006386.7

(2) 陈填烽; 曾德龙; 赵建夫, 一种抗肿瘤的联合用药物, 2017.1.22, 中国, 20 1710052841.0